The economic implications of therapeutic conservatism

Area of Science:

• Pharmacoeconomics
• Pharmaceutical Market Analysis
• Health Policy

Background:

• The United Kingdom (UK) has historically exhibited a more conservative pattern of medicine prescribing compared to other major European markets.
• This conservative trend in British prescription medicine is becoming increasingly pronounced when compared internationally.

Purpose of the Study:

• To analyze and compare medicine prescribing patterns in the UK against other European markets.
• To identify key indicators of the conservative nature of the British prescription medicine market.

Main Methods:

• International comparison of prescribing data across European countries.
• Analysis of prescription frequency per patient.
• Assessment of the uptake of new active chemical entities (NCEs).
• Evaluation of reliance on a smaller number of active substances.

Main Results:

• British doctors prescribe fewer items per patient annually than their European counterparts.
• There is a lower likelihood of British doctors prescribing products with new active chemical entities (NCEs) compared to other European countries, a trend that has intensified over the last decade.
• Prescribing in the UK shows an increasing reliance on a smaller set of active substances.

Conclusions:

• The conservative prescribing in the UK leads to increased pharmaceutical industry dependence on older products and "blockbuster" drugs for research funding.
• Reduced uptake of novel medicines and a shift towards generics diminish pharmaceutical companies' capacity to invest in research for new treatments.
• These trends may negatively affect both patient access to innovative treatments and the British economy.